| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Apr 19, 2024 | Option Exercise | $4.51 | 2,250 | 10,148 | 9,807 | Apr 23, 2024, 04:39 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Apr 19, 2024 | Option Exercise | $4.51 | 3,957 | 17,846 | 30,554 | Apr 23, 2024, 04:35 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Executive Chairman | Apr 19, 2024 | Option Exercise | $4.51 | 10,125 | 45,664 | 50,876 | Apr 23, 2024, 04:31 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Apr 19, 2024 | Option Exercise | $4.51 | 6,088 | 27,457 | 95,636 | Apr 23, 2024, 04:26 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Executive Chairman | Mar 04, 2024 | Buy | $4.59 | 10,000 | 45,850 | 38,501 | Mar 06, 2024, 04:49 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Mar 04, 2024 | Buy | $4.59 | 10,000 | 45,850 | 76,724 | Mar 06, 2024, 04:43 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | May 30, 2023 | Buy | $5.50 | 5,000 | 27,500 | 66,730 | Jun 01, 2023, 05:42 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Apr 28, 2023 | Option Exercise | $8.29 | 669 | 5,546 | 6,432 | May 01, 2023, 05:55 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Apr 28, 2023 | Option Exercise | $8.29 | 609 | 5,049 | 18,261 | May 01, 2023, 05:54 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Apr 28, 2023 | Option Exercise | $8.29 | 1,827 | 15,146 | 61,730 | May 01, 2023, 05:53 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Executive Chairman | Apr 28, 2023 | Option Exercise | $8.29 | 2,250 | 18,652 | 28,501 | May 01, 2023, 05:51 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Apr 21, 2023 | Option Exercise | $6.80 | 5,863 | 39,868 | 56,057 | Apr 25, 2023, 04:28 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Apr 21, 2023 | Option Exercise | $6.80 | 3,811 | 25,915 | 16,370 | Apr 25, 2023, 04:27 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Apr 21, 2023 | Option Exercise | $6.80 | 3,010 | 20,468 | 5,851 | Apr 24, 2023, 04:17 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Executive Chairman | Apr 21, 2023 | Option Exercise | $6.80 | 10,125 | 68,850 | 25,751 | Apr 24, 2023, 04:15 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Apr 21, 2023 | Option Exercise | $6.80 | 4,819 | 32,769 | 15,362 | Apr 24, 2023, 04:14 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Apr 21, 2023 | Option Exercise | $6.80 | 7,324 | 49,803 | 54,596 | Apr 24, 2023, 04:13 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Aug 16, 2022 | Option Exercise | $4.37 | 3,059 | 13,368 | 14,920 | Aug 18, 2022, 04:39 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Aug 16, 2022 | Option Exercise | $4.37 | 1,817 | 7,940 | 3,931 | Aug 18, 2022, 04:39 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Aug 16, 2022 | Option Exercise | $4.37 | 3,093 | 13,516 | 3,502 | Aug 18, 2022, 04:38 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Clarke Anthony | CSO | Apr 28, 2022 | Option Exercise | $7.43 | 250 | 1,857 | 3,502 | Apr 29, 2022, 04:51 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Apr 28, 2022 | Option Exercise | $7.43 | 669 | 4,971 | 675 | Apr 29, 2022, 04:50 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Executive Chairman | Apr 28, 2022 | Option Exercise | $7.43 | 2,250 | 16,717 | 13,376 | Apr 29, 2022, 04:46 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Apr 28, 2022 | Option Exercise | $7.43 | 609 | 4,525 | 2,114 | Apr 29, 2022, 04:43 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Apr 28, 2022 | Option Exercise | $7.43 | 1,827 | 13,575 | 11,861 | Apr 29, 2022, 04:39 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CEO | Aug 17, 2021 | Option Exercise | $6.81 | 21 | 143 | 6,188 | Aug 19, 2021, 05:11 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | President & CMO | Aug 17, 2021 | Option Exercise | $6.81 | 21 | 143 | 223 | Aug 19, 2021, 05:09 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Wan Jerry | Principal Accounting Officer | Aug 17, 2021 | Option Exercise | $6.81 | 6 | 41 | 94 | Aug 19, 2021, 05:07 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CFO & COO | Aug 18, 2020 | Option Exercise | $8.95 | 33 | 295 | 141 | Aug 19, 2020, 04:26 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | EVP, CMO | Aug 18, 2020 | Option Exercise | $8.95 | 33 | 295 | 176 | Aug 19, 2020, 04:25 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | EVP, CMO | Aug 13, 2018 | Option Exercise | $1.88 | 408 | 767 | 2,801 | Aug 15, 2019, 05:15 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CFO & COO | Aug 13, 2019 | Option Exercise | $1.88 | 408 | 767 | 2,101 | Aug 15, 2019, 05:10 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Boyd Steven | 10% Owner | Jun 11, 2019 | Sale | $2.86 | 47,182 | 134,821 | 841,576 | Jun 13, 2019, 05:20 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Armistice Capital Master Fund Ltd. | 10% Owner | Jun 11, 2019 | Sale | $3.19 | 277,776 | 886,157 | 1,066,202 | Jun 13, 2019, 05:15 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Stewart Richard Alistair | Chairman & CEO | May 23, 2019 | Buy | $3.61 | 17,500 | 63,093 | 212,530 | May 28, 2019, 06:01 AM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | EVP, CMO | Jan 15, 2019 | Option Exercise | $1.16 | 13 | 15 | 1,839 | Jan 17, 2019, 05:32 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CFO & COO | Jan 15, 2019 | Option Exercise | $1.16 | 9 | 10 | 1,139 | Jan 17, 2019, 05:30 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | JACOBS CINDY | EVP, CMO | Aug 13, 2018 | Option Exercise | $2.78 | 472 | 1,312 | 1,810 | Aug 15, 2018, 04:55 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CFO & COO | Aug 13, 2018 | Option Exercise | $2.78 | 458 | 1,273 | 1,120 | Aug 15, 2018, 04:52 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Bencich John | CFO | Sep 08, 2017 | Option Exercise | $3.09 | 149 | 460 | 1,358 | Sep 12, 2017, 02:30 PM | |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | Cormack Scott Daniel | Director | Sep 08, 2017 | Option Exercise | $3.09 | 1,491 | 4,607 | 14,810 | Sep 12, 2017, 02:28 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jun 12, 2017 | Option Exercise | $0.36 | 4,472 | 1,610 | 144,953 | Jun 14, 2017, 04:39 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Jun 12, 2017 | Option Exercise | $0.36 | 1,633 | 588 | 87,726 | Jun 14, 2017, 04:30 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Jan 10, 2017 | Option Exercise | $0.63 | 3,369 | 2,122 | 84,359 | Jan 12, 2017, 11:48 AM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Bencich John | CFO | Jan 10, 2017 | Option Exercise | $0.63 | 1,021 | 643 | 11,588 | Jan 12, 2017, 11:42 AM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jan 10, 2017 | Option Exercise | $0.63 | 9,690 | 6,105 | 140,050 | Jan 12, 2017, 11:31 AM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Bencich John | CFO | Aug 19, 2016 | Sale | $0.57 | 1,380 | 787 | 9,484 | Aug 23, 2016, 06:16 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Jun 13, 2016 | Sale | $1.03 | 1,437 | 1,473 | 77,416 | Jun 15, 2016, 05:52 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jun 13, 2016 | Sale | $1.03 | 4,856 | 4,979 | 129,428 | Jun 15, 2016, 05:50 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Mar 15, 2016 | Sale | $0.83 | 3,254 | 2,701 | 73,853 | Mar 16, 2016, 06:31 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Bencich John | CFO | Mar 15, 2016 | Sale | $0.83 | 834 | 692 | 5,864 | Mar 16, 2016, 06:29 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Mar 15, 2016 | Sale | $0.83 | 12,033 | 9,987 | 124,909 | Mar 16, 2016, 06:26 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Clendeninn Neil James | Director | Oct 28, 2015 | Option Exercise | $2.69 | 5,359 | 14,416 | 19,921 | Oct 30, 2015, 11:23 AM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Bencich John | CFO | Aug 18, 2015 | Sale | $2.76 | 1,427 | 3,939 | 3,573 | Aug 20, 2015, 01:03 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Jun 12, 2015 | Sale | $2.69 | 1,408 | 3,788 | 64,919 | Jun 16, 2015, 03:08 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jun 12, 2015 | Sale | $2.69 | 4,571 | 12,296 | 111,942 | Jun 16, 2015, 03:06 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | May 20, 2015 | Sale | $1.88 | 2,092 | 3,933 | 61,327 | May 21, 2015, 06:29 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | May 20, 2015 | Sale | $1.88 | 7,543 | 14,181 | 107,138 | May 21, 2015, 06:28 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jan 30, 2015 | Option Exercise | $2.11 | 9,206 | 19,425 | 99,057 | Jan 30, 2015, 06:46 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Jan 30, 2015 | Option Exercise | $2.11 | 4,376 | 9,233 | 55,919 | Jan 30, 2015, 06:44 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Sep 19, 2014 | Option Exercise | $3.06 | 1,310 | 4,009 | 46,895 | Sep 19, 2014, 03:38 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Sep 19, 2014 | Option Exercise | $3.06 | 3,401 | 10,407 | 88,163 | Sep 19, 2014, 03:31 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Aug 13, 2014 | Sale | $3.17 | 5,650 | 17,911 | 43,255 | Aug 14, 2014, 06:11 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Aug 13, 2014 | Sale | $3.17 | 18,341 | 58,141 | 84,139 | Aug 14, 2014, 06:01 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Wyrick Susan D. | PAO | Mar 17, 2014 | Sale | $12.25 | 182 | 2,230 | 1,312 | Mar 18, 2014, 07:23 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Mar 17, 2014 | Sale | $12.25 | 1,250 | 15,313 | 28,905 | Mar 18, 2014, 07:23 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Mar 17, 2014 | Sale | $12.25 | 4,634 | 56,767 | 64,980 | Mar 18, 2014, 07:22 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Aug 19, 2013 | Sale | $8.68 | 1,364 | 11,840 | 25,780 | Oct 07, 2013, 03:26 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Mar 12, 2013 | Sale | $11.90 | 534 | 6,355 | 22,551 | Oct 07, 2013, 03:23 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Aug 19, 2013 | Sale | $8.68 | 3,112 | 27,012 | 60,238 | Oct 07, 2013, 03:21 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Mar 12, 2013 | Sale | $11.90 | 2,134 | 25,395 | 56,788 | Oct 07, 2013, 03:19 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Wyrick Susan D. | PAO | Aug 19, 2013 | Sale | $8.68 | 194 | 1,684 | 481 | Oct 03, 2013, 08:11 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Wyrick Susan D. | PAO | Oct 02, 2013 | Sale | $9.04 | 191 | 1,727 | 978 | Oct 03, 2013, 08:11 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Smith David V | Director | May 23, 2013 | Option Exercise | $10.64 | 2,000 | 21,280 | 2,000 | May 28, 2013, 12:34 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | PARKER H STEWART | Director | May 23, 2013 | Option Exercise | $10.64 | 2,000 | 21,280 | 5,000 | May 28, 2013, 12:33 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | MATTINGLY MARTIN A | Director | May 23, 2013 | Option Exercise | $10.64 | 2,000 | 21,280 | 3,000 | May 28, 2013, 12:31 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | GOLDSTEIN JACK | Director | May 23, 2013 | Option Exercise | $10.64 | 2,000 | 21,280 | 3,000 | May 28, 2013, 12:30 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Clendeninn Neil James | Director | May 23, 2013 | Option Exercise | $10.64 | 2,000 | 21,280 | 9,562 | May 28, 2013, 12:25 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Clendeninn Neil James | Director | Oct 18, 2012 | Option Exercise | $4.11 | 513 | 2,106 | 7,562 | Oct 19, 2012, 03:01 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | GOLDSTEIN JACK | Director | Aug 15, 2012 | Buy | $14.38 | 1,000 | 14,381 | 1,000 | Aug 16, 2012, 02:31 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Clendeninn Neil James | Director | Aug 03, 2012 | Option Exercise | $4.11 | 3,702 | 15,197 | 7,049 | Aug 07, 2012, 06:27 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Aug 07, 2012 | Option Exercise | $4.11 | 7,000 | 28,736 | 54,234 | Aug 07, 2012, 01:57 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jul 30, 2012 | Option Exercise | $4.11 | 34,167 | 140,259 | 47,234 | Aug 01, 2012, 06:03 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | MATTINGLY MARTIN A | Director | Jun 01, 2012 | Buy | $12.46 | 1,000 | 12,460 | 1,000 | Jun 04, 2012, 12:39 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Aug 16, 2011 | Option Exercise | $4.11 | 11,210 | 46,018 | 21,210 | Aug 17, 2011, 06:45 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | PARKER H STEWART | Director | Aug 09, 2011 | Buy | $10.09 | 3,000 | 30,275 | 3,000 | Aug 09, 2011, 07:14 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | JACOBS CINDY | EVP, CMO | Aug 05, 2011 | Option Exercise | $4.11 | 10,000 | 41,051 | 10,000 | Aug 08, 2011, 02:33 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Aug 05, 2011 | Option Exercise | $4.11 | 5,000 | 20,526 | 18,067 | Aug 08, 2011, 02:30 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Clendeninn Neil James | Director | Jul 01, 2011 | Option Exercise | $3.89 | 3,347 | 13,016 | 3,347 | Jul 06, 2011, 12:50 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Lawrence Cameron William | Principal Accounting Officer | Feb 22, 2011 | Option Exercise | $3.00 | 1,400 | 4,200 | 4,450 | Feb 24, 2011, 05:04 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Lawrence Cameron William | Principal Accounting Officer | Feb 22, 2011 | Option Exercise | $3.00 | 475 | 1,425 | 950 | Feb 24, 2011, 05:04 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jan 04, 2011 | Option Exercise | $10.20 | 13,216 | 134,863 | 19,675 | Jan 06, 2011, 07:05 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jan 04, 2011 | Sale | $10.20 | 6,784 | 69,227 | 11,484 | Jan 06, 2011, 07:05 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Jan 05, 2011 | Option Exercise | $3.89 | 8,660 | 33,679 | 21,727 | Jan 06, 2011, 07:05 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Dec 08, 2010 | Option Exercise | $9.92 | 10,000 | 99,195 | 13,092 | Dec 10, 2010, 12:11 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Dec 03, 2010 | Option Exercise | $3.89 | 5,000 | 19,445 | 18,067 | Dec 03, 2010, 04:52 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Dec 01, 2010 | Sale | $9.95 | 10,000 | 99,545 | 18,067 | Dec 03, 2010, 04:52 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Nov 15, 2010 | Sale | $9.94 | 10,000 | 99,395 | 13,092 | Nov 17, 2010, 04:19 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Cormack Scott Daniel | President and CEO | Nov 16, 2010 | Option Exercise | $3.89 | 5,000 | 19,445 | 18,067 | Nov 17, 2010, 04:19 PM | |
| OGXI | ONCOGENEX PHARMACEUTICALS, INC. | Lawrence Cameron William | Principal Financial Officer | Nov 09, 2010 | Buy | $15.73 | 650 | 10,224 | 3,050 | Nov 10, 2010, 12:27 PM |
Menu